Cardiol Therapeutics Inc.
CRDL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $131,737 | $71,962 | $43,168 | $101,076 |
| - Cash | $30,580 | $34,932 | $43,825 | $83,899 |
| + Debt | $159 | $174 | $54 | $118 |
| Enterprise Value | $101,316 | $37,205 | -$604 | $17,294 |
| Revenue | $0 | $0 | $0 | $62 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$187 | -$162 | -$112 |
| % Margin | – | – | – | -179.9% |
| EBITDA | -$40,115 | -$21,035 | -$22,655 | -$24,839 |
| % Margin | – | – | – | -39,891% |
| Net Income | -$36,677 | -$21,223 | -$22,818 | -$25,013 |
| % Margin | – | – | – | -40,170.9% |
| EPS Diluted | -0.51 | -0.44 | -0.49 | -0.73 |
| % Growth | -15.9% | 10.2% | 32.9% | – |
| Operating Cash Flow | -$25,061 | -$25,180 | -$27,220 | -$23,551 |
| Capital Expenditures | -$21 | -$64 | -$75 | -$13 |
| Free Cash Flow | -$25,082 | -$25,245 | -$27,295 | -$23,564 |